Verapamil Impurity 17 | CAS 1835-02-5 - Request Quote
Verapamil Impurity 17
| SZ CAT No: | SZ-V021048 |
| CAS No | 1835-02-5 |
| Mol.F. | C10H11BrO3 |
| Mol.Wt. | 259.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Verapamil Impurity 17 is chemically 2-Bromo-1-(3,4-dimethoxyphenyl)ethan-1-one. Verapamil Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Verapamil Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Verapamil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1835-02-5
Purchase 1835-02-5
Order 1835-02-5
Enquire 1835-02-5
price of 1835-02-5
1835-02-5 Supplier
1835-02-5 Manufacturer
1835-02-5 Exporter
buy high quality Verapamil Impurity 17
Purchase Verapamil Impurity 17
Verapamil Impurity 17 suppliers
Verapamil Impurity 17 manufacturers
Verapamil Impurity 17 price
Order Verapamil Impurity 17
Enquire Verapamil Impurity 17
Verapamil Impurity 17 cost
Verapamil Impurity 17 Supplier
Verapamil Impurity 17 Distributor
Verapamil Impurity 17 for Method Validation
Verapamil Reference Standard
Verapamil Impurity 17 for ANDA Filing
Verapamil Impurity 17 for Forced Degradation Studies
Verapamil Impurity 17 Identification Standards
Verapamil Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.